The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: A resource for the development of change‐analysis software

G McLennan, AP Reeves… - Clinical …, 2008 - Wiley Online Library
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: A resource for the development of change-analysis software

SG Armato, CR Meyer… - Clinical …, 2008 - mdanderson.elsevierpure.com
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change Analysis Software

SG Armato, G McLennan, CR Meyer… - Clinical pharmacology …, 2008 - iro.uiowa.edu
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

[引用][C] The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change-Analysis …

SG ARMATO, CR MEYER… - Clinical …, 2008 - pascal-francis.inist.fr
The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER)
Project : A Resource for the Development of Change-Analysis Software CNRS Inist Pascal-Francis …

The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software

SG Armato, CR Meyer, MF Mcnitt-Gray… - Clinical …, 2008 - research.ed.ac.uk
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change-Analysis Software.

SG Armato, CR Meyer, MF McNitt-Gray… - Clinical …, 2008 - search.ebscohost.com
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.

SG Armato 3rd, CR Meyer, MF Mcnitt-Gray… - Clinical …, 2008 - europepmc.org
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software

SG Armato III, CR Meyer, MF McNitt-Gray, G McLennan… - 2008 - repository.lincoln.ac.uk
Critical to the clinical evaluation of effective novel therapies for lung cancer is the early and
accurate determination of tumor response, which requires an understanding of the sources …

[PDF][PDF] The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change‐Analysis …

SG Armato, CR Meyer, M Mcnitt‐gray, G McLennan… - 2008 - deepblue.lib.umich.edu
BACKGROUND Lung cancer, the most common cause of cancer death in both men and
women in the United States, has a 15% overall 5-year survival rate1—a survival rate that …

[PDF][PDF] The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change-Analysis …

SGA III, CR Meyer, MF McNitt-Gray… - CLINICAL …, 2008 - academia.edu
BACKGROUND Lung cancer, the most common cause of cancer death in both men and
women in the United States, has a 15% overall 5-year survival rate1—a survival rate that …